UNITED  STATES
                       SECURITIES  AND  EXCHANGE  COMMISSION
                              Washington,  D.C.  20549


                                  SCHEDULE  13E-3

             RULE  13E-3  TRANSACTION  STATEMENT  UNDER  SECTION  13(e)
                    OF  THE  SECURITIES  EXCHANGE  ACT  OF  1934
                              (Amendment  No.  ____)


                                 Paris  Corporation
                              (Name  of  the  Issuer)

          Paris  Corporation,  Dominic  P.  Toscani,  Sr.  and Gerard M. Toscani
                         (Names  of  Persons  Filing  Statement)

                                   Common  Stock
                          (Title  of  Class  of  Securities)

    ________________________________________________________________________
                      (CUSIP  Number  of  Class  of  Securities)

                              Stephen  A.  Salvo,  Esq.
                         Salvo  Russell,  Fichter  &  Landau
              510  Township  Line  Road,  Suite  150,  Blue  Bell,  PA  19422
                                 (215)  653-0110
     (Name,  Address,  and  Telephone  Numbers  of  Person Authorized to Receive
      Notices  and  Communications  on  Behalf  of the Persons Filing Statement)




This  statement  is  filed  in  connection  with  (check  the  appropriate box):

a.   The filing of solicitation materials or an information statement subject to
     Regulation 14A (Section 240.14a-1 through 240.14b-2), Regulation 14C
     (Section 240.14c-1 through 240.14c-101) or Rule 13e-3(c) (Section
     240.13e-3(c)) under the Securities Exchange Act of 1934 ("the Act").

b.    The  filing of a registration statement under the Securities Act of 1933.

c.    _X_  A  tender  offer.

d.    None  of  the  above.

Check  the  following  box  if the soliciting materials or information statement
referred  to  in  checking  box  (a)  are  preliminary  copies:  _____

Check the following box if the filing is a final amendment reporting the results
of  the  transaction:  _____

                         Calculation  of  Filing  Fee

     Transaction  valuation*                      Amount  of  filing  fee
          $15,313,536                                     $3,063


*  For purposes of calculating the amount of filing fee only. The amount assumes
the  purchase  of  3,403,008  shares of common stock, par value $0.004 per share
(the  "Shares"),  of  Paris Corporation (the "Company"), at a price per share of
$4.50.  Such  number  of  shares  represents  all  the  Shares outstanding as of
December  31,  2001  (other  than  150,527 shares beneficially held by Gerard M.
Toscani),  plus  162,300 shares issuable upon exercise of outstanding options to
purchase  Shares.

__X__ Check  the box if any part of the fee is offset as provided by Section
      240.0-11(a)(2)  and  identify  the filing with which the offsetting fee
      was previously  paid.  Identify  the  previous filing by registration
      statement number,  or  the  Form  or  Schedule  and  the  date  of  its
      filing.


Amount  Previously  Paid:  $3,063

Form  or  Registration  No.:  Schedule  TO-I

Filing Party:  Dominic P. Toscani, Sr., Gerard M. Toscani and Paris Corporation

Date  Filed:  January  31,  2002



Item  1.    Summary  Term  Sheet.

Furnish  the  information  required by Item 1001 of Regulation M-A (Section
229.1001  of  this  chapter)  unless  information  is disclosed to security
holders  in  a prospectus that meets the requirements of Section 230.421(d)
of  this  chapter.


- -  Paris  Corporation, a Pennsylvania corporation (the "Company"), hereby offers
to purchase any and all of its shares of Common Stock $0.004 par value per share
(the  "Shares"), at $4.50 per Share (the "Purchase Price"), net to the seller in
cash, without interest thereon, upon the terms and subject to the conditions set
forth in this Offer to Purchase and in the related Letter of Transmittal (which,
together  with  any  amendments  or  supplements hereto or thereto, collectively
constitute  the  "Offer") previously filed by the Company on Schedule TO-I dated
January  31,  2002.

- - The Offer is not conditioned upon any minimum number of Shares being tendered.
The  Offer is, however, subject to certain other conditions. All Shares properly
tendered  and  not  properly  withdrawn will be purchased at the Purchase Price,
upon  the  terms  and  subject  to  the  conditions  of  the  Offer.

- -  Tendering  stockholders  will  not  be  obligated  to  pay  brokerage fees or
commissions  or,  except  as  set  forth  in  Instruction  6  of  the  Letter of
Transmittal,  transfer taxes in connection with the tender of Shares pursuant of
the  Offer.  The  Company  will  pay all fees and expenses which Mellon Investor
Services  LLC,  which  is acting as Depositary (the "Depositary"), and MacKenzie
Partners,  Inc.,  which  is  acting  as  the Information Agent (the "Information
Agent"),  incur  in  connection  with  the  Offer.

- -  The  Offer and withdrawal rights will expire at 12:00 midnight, New York City
time  on  March  15,  2002  unless  the  Offer  is  extended.

- -  Paris Corporation shares are traded on the NASDAQ Small Cap Market ("NASDAQ")
under  the ticker symbol PBFI.  On January 9, 2002, the last day the shares were
traded on NASDAQ before announcement of the Offer, the last reported sales price
of  the  Shares  on  NASDAQ  was  $3.35  per  Share.


Item  2.     Subject  Company  Information.

Furnish  the  information  required  by  Item  1002  of  Regulation M-A (Section
229.1002  of  this  chapter).


a)    Name  and  Address  of  Subject  Company/Issuer

     Paris  Corporation
     122  Kissell  Road
     Burlington,  NJ  08016

     Address  and  Phone  Number  of  Paris  Corporation's  Principal  Executive
     Offices

     122  Kissell  Road
     Burlington,  NJ  08016
     (609)  387  -  7300

b)   Title  and  Number  of  Shares  Outstanding

As of December 31, 2001, there were 3,391,235 shares of Common Stock outstanding
with  257,300  shares reserved for future issuance pursuant to outstanding stock
options

c)    Trading  and  Market  Price

The  Shares  are  traded  on NASDAQ Small Cap Market ("NASDAQ") under the ticker
symbol  PBFI.  The  highest  and  lowest sale prices for the shares for last two
years  (on  a  quarterly  basis)  are  as  follows:



YEAR  ENDED  DECEMBER  31,  2000:

First  Quarter.         $2.6250          2.0000
Second  Quarter          2.1250          1.8750
Third  Quarter.          2.3750          1.7812
Fourth  Quarter          2.1875          1.7812


YEAR  ENDED  DECEMBER  31,  2001:

First  Quarter.         $2.8750          1.8750
Second  Quarter          3.6000          2.4375
Third  Quarter.          3.6000          2.5000
Fourth  Quarter.         3.2300          2.5000

On  January  9,  2002,  the  last  day  the  shares  were  traded  prior  to the
announcement  of  the Offer, the last reported sales price per Share as reported
on  the  NASDAQ  was  $3.35  per  share.


d)    Dividends

During  the  past  10  years  the Company has declared two cash dividends on the
Shares;  a  $0.20  per  Share  dividend  in  January  1999 and a $0.10 per Share
dividend  in  March 2000.  The Company does not anticipate paying cash dividends
on  the  Shares  in the foreseeable future. The Company intends to retain future
earnings  to  finance its operations and to fund the growth of the business. Any
payment  of future dividends will be at the discretion of the Board of Directors
and  will  depend  upon,  among  other things, the Company's earnings, financial
condition, capital requirements, level of indebtedness, contractual restrictions
with  respect  to  the  payment of dividends and other factors that the Board of
Directors  deems  relevant

e)    Prior  Public  Offerings

      None

f)    Prior  Stock  Purchases
      None


Item  3.

Identity  and  Background  of  Filing  Person.

Furnish  the information required by Item 1003(a) through (c) of Regulation
M-A  (Section  229.1003  of  this  chapter).


a)   Name  and  Business  Addresses  of  Filing  Persons

     Paris  Corporation  -  Subject  Company
     122  Kissell  Road
     Burlington,  NJ  08016
     (609)  387  -  7300

     Dominic  P.  Toscani,  Sr.  -  President,  Treasurer,  Chairman
     and  Chief  Financial  Officer  of  Paris  Corporation
     122  Kissell  Road
     Burlington,  NJ  08016
     (609)  387  -  7300

     Gerard  M.  Toscani  -  Senior  Vice  President  of  Paris  Corporation
     122  Kissell  Road
     Burlington,  NJ  08016
     (609)  387  -  7300


b)    Background  and  Business  of  Entities

      Not  Applicable


c)    Background  and  Business  of  Natural  Persons

      1) Current  Principal  Occupation

         Dominic  P.  Toscani,  Sr.  -  President,  Treasurer,  Chairman
         and  Chief  Financial  Officer  of  Paris  Corporation
         122  Kissell  Road
         Burlington,  NJ  08016

         Gerard  M.  Toscani  -  Senior  Vice  President  of  Paris  Corporation
         122  Kissell  Road
         Burlington,  NJ  08016


     2)  Neither Dominic P. Toscani, Sr. nor Gerard M. Toscani has had any other
material  occupations,  positions,  offices  or  employment during the past five
years.

     3)  Neither  Dominic  P.  Toscani,  Sr.  nor  Gerard  M.  Toscani  has been
convicted  in  a  criminal  proceeding  during  the  past  five  years.

     4)  Neither Dominic P. Toscani, Sr. nor Gerard M. Toscani have been a party
to  any  judicial  or  administrative proceeding during the past five years that
resulted  in  a  judgment,  decree  or  final  order enjoining them from further
violations of, or prohibiting activities subject to, federal or state securities
laws,  or  a  finding  of  any  violation  of  federal or state securities laws.

     5)  Both  Dominic  P.  Toscani, Sr. and Gerard M. Toscani are United States
citizens.


Item  4.  Terms  of  the  Transaction.

Furnish  the  information  required  by  Item  1004(a)  and  (c)  through (f) of
Regulation  M-A  (Section  229.1004  of  this  chapter).

a)   Material  Terms

     This  Schedule  13e-3 relates to the offer by Paris Corporation to purchase
any  and  all  outstanding  shares of its own common stock, par value $0.004 per
share,  at  a purchase price of $4.50 per Share, net to the seller in cash, upon
the terms and subject to the conditions set forth in the Offer to Purchase dated
January  31,  2002  (the  "Offer  to  Purchase")  and  in  the related Letter of
Transmittal  (which,  together  with  any  amendments  or  supplements  thereto,
collectively  constitute the "Offer"). The information set forth in the Offer to
Purchase  and  the  related  Letter  of  Transmittal  is  incorporated herein by
reference with respect to Items 1-9 and 13 of the Schedule TO-I previously filed
by  the  company on January 31, 2002 as amended by Schedule TO-I/A (Amendment 2)
previously  filed  by  the  Company  on  March  5,  2002.

     The  Offer  and  withdrawal  rights will expire at 12:00 midnight, New York
City  time  on  March  15,  2002  unless  the  Offer  is  extended.

b)   Purchases

     Gerard  M. Toscani, Senior Vice President of Paris Corporation, and Dominic
P.  Toscani, President and Chief Executive Officer of Paris Corporation, who own
or control approximately 4.8% and 44.9%, respectively, of the outstanding Common
Stock,  have indicated that they will not tender their shares in the offer.  All
other executive officers, directors, affiliates and subsidiaries (if any) of the
filing  persons have indicated their intent to tender their shares in the offer.

c)     Different  Terms

       Not  Applicable

f)     Eligibility  for  listing  or  trading

       Not  Applicable

Item  5.   Past  Contacts,  Transactions,  Negotiations  and  Agreements.

Furnish  the  information  required  by  Item  1005(a)  through  (c)  and (e) of
Regulation  M-A  (Section  229.1005  of  this  chapter).

a)      Transactions

There  have  been  no  transactions,  other than those disclosed in the Offer to
Purchase and the related Letter of Transmittal, which are incorporated herein by
reference  with  respect  to  Items 1-9 and 13 of the Schedule TO-I filed by the
Company  on  January  31,  2002  as amended by Schedule TO-I/A (Amendment No. 2)
filed  by  the  Company  on  March  5,  2002.

b)      Significant  Corporate  Events

There  have  been no significant corporate events, other than those disclosed in
the  Offer  to  Purchase  and  the  related  Letter  of  Transmittal,  which are
incorporated  herein  by  reference  with  respect  to  Items  1-9 and 13 of the
Schedule  TO-I  filed  by the Company on January 31, 2002 as amended by Schedule
TO-I/A  (Amendment  No.  2)  filed  by  the  Company  on  March  5,  2002.

c)      Negotiations  or  Contacts

There  have  been no negotiations or contacts, other than those disclosed in the
Offer  to Purchase and the related Letter of Transmittal, which are incorporated
herein  by reference with respect to Items 1-9 and 13 of the Schedule TO-I filed
by  the Company on January 31, 2002 as amended by Schedule TO-I/A (Amendment No.
2)  filed  by  the  Company  on  March  5,  2002.


e)      Agreements  involving  subject  company's  securities

        Not  Applicable


Item  6.   Purposes  of  the  Transaction  and  Plans  or  Proposals.

Furnish  the  information  required  by  Item 1006(b) and (c) (1) through (8) of
Regulation  M-A  (Section  229.1006  of  this  chapter).

b)    Use  of  Securities

The information set forth under "SPECIAL FACTORS - Background and Purpose of the
Offer; Steps Leading up to the Tender Offer; Certain Effects of the Offer; Plans
of  the  Company  After the Offer" of the Offer to Purchase filed as Exhibit (a)
(1)  to  Schedule  TO-I  dated  January  31, 2002, as amended by Schedule TO-I/A
(Amendment  No.  2)  filed  March 5, 2002, are incorporated herein by reference.


c)   Plans

The information set forth under "SPECIAL FACTORS - Background and Purpose of the
Offer; Steps Leading up to the Tender Offer; Certain Effects of the Offer; Plans
of  the  Company  After the Offer" of the Offer to Purchase filed as Exhibit (a)
(1)  to  Schedule  TO-I  dated  January  31, 2002, as amended by Schedule TO-I/A
(Amendment  No.  2)  filed  March 5, 2002, are incorporated herein by reference.


Item  7.   Purposes,  Alternatives,  Reasons  and  Effects.

Furnish  the  information  required by Item 1013 of Regulation M-A (Section
229.1013  of  this  chapter).


a)   Purposes

The  offer  represents  the  first  step  in  taking  the Company private. After
completion  of  the  offer,  Paris  Corporation intends to propose a Second-Step
Transaction,  a  merger,  a reverse stock split or similar transaction, in which
all  of the remaining public stockholders would receive cash for their shares at
the  same  price  as  is  contemplated  in  the  offer.

b)   Alternatives

Management  of  Paris Corporation also considered the sale of the company or its
principal  operating  units.  Wharton  Valuation Associates, Inc. was engaged by
Paris  Corporation  on  October  13,  2000 to analyze the value of the company's
business  units  for  that purpose. Wharton reviewed publicly available business
and  financial  information  and  Paris  Corporation provided Wharton with draft
financial  results and forecasts.  Representatives of Paris Corporation also met
with  business  brokers and solicited interest in the company. It was determined
that  the  fees  charged  by  brokers would significantly reduce the value which
Paris  Corporation  would receive in a brokered transaction, and the company was
unable  to  generate  an  offer  in  its  independent  solicitations.


c)   Reasons

The information set forth under "SPECIAL FACTORS - Background and Purpose of the
Offer; Steps Leading up to the Tender Offer; Certain Effects of the Offer; Plans
of  the  Company  After  the Offer" and "SPECIAL FACTORS -Position of the Board;
Fairness  of  the  Offer"  of  the  Offer to Purchase filed as Exhibit (a)(1) to
Schedule  TO-I  dated January 31, 2002, as amended by Schedule TO-I/A (Amendment
No.  2)  filed  March  5,  2002,  are  incorporated  herein  by  reference.

d)   Effects

The  information  set forth under "THE TENDER OFFER - Certain Federal Income Tax
Consequences"  and "THE TENDER OFFER - Effect of the Offer on the Market for the
Shares; NASDAQ Listing and Exchange Registration" of the Offer to Purchase filed
as  Exhibit  (a)  (1)  to  Schedule  TO-I  dated January 31, 2002, as amended by
Schedule  TO-I/A  (Amendment No. 2) filed March 5, 2002, are incorporated herein
by  reference.


Item  8.   Fairness  of  the  Transaction.

Furnish the information required by Item 1014 of Regulation M-A (Section
229.1014 of this chapter).

a)   Fairness

The Board of Directors of the Company, which consists of Dominic Toscani, Gerard
Toscani,  Frank  Mattei  (who collectively own approximately 78.3 percent of the
issued  and  outstanding  shares of the Company's common stock) and four outside
directors,  unanimously  approved  the  offer,  concluding  that  the  offer  is
advisable and that the terms of the offer are fair to, and in the best interests
of,  our  company  and its unaffiliated shareholders. Gerard Toscani and Dominic
Toscani,  who  abstained from the Board vote because of their potential conflict
of  interest,  also  believe  the  Offer  is  fair  to  the  other stockholders.

b)    Factors  Considered

The  information  set  forth  under  "SPECIAL  FACTORS - Positions of the Board;
Fairness."  of  the  Offer to Purchase filed as Exhibit (a) (1) to Schedule TO-I
dated  January  31,  2002  as amended by Schedule TO-I/A (Amendment No. 2) filed
March  5,  2002  and  the written Opinion of Wharton Valuation Associates, Inc.,
dated  November 27, 2001 (Included as Schedule III to the Offer to Purchase) are
incorporated  herein  by  reference.

c)   Approval  of  Security  Holders

No  approval  of  the  unaffiliated security holders was required for the tender
offer.  The  Second-Step  Transaction  may require approval by the stockholders,
depending on the nature of the Second-Step Transaction.  However, because Gerard
M.  Toscani  and Dominic P. Toscani currently own or control approximately 49.7%
of  the  outstanding  common  stock  and may hold a greater percentage after the
offer,  they  may be able to control the outcome of any Second-Step Transaction.

d)   Unaffiliated  Representative

     Not  Applicable

e)   Approval  of  Directors

Please  see  previous  response  to  Section  8a  (Fairness).

f)    Other  Offers

      None

Item  9.   Reports,  Opinions,  Appraisals  and  Negotiations.

Furnish  the  information  required by Item 1015 of Regulation M-A (Section
229.1015  of  this  chapter).


a)    Report,  opinion  or  appraisal

The Board of Directors of the Company received an opinion from Wharton Valuation
Associates,  Inc.  relating  to  the  fairness  of  the  offering  to  public
stockholders.

b)    Summary  of  Report,  opinion  or  appraisal

The  information set forth under "SPECIAL FACTORS - Opinion of Wharton Valuation
Associates,  Inc." of the Offer to Purchase filed as Exhibit (a) (1) to Schedule
TO-I  dated  January  31,  2002  as amended by Schedule TO-I/A (Amendment No. 2)
filed  March  5,  2002  and the written Opinion of Wharton Valuation Associates,
Inc.,  dated  November  27,  2001  (Included  as  Schedule  III  to the Offer to
Purchase)  are  incorporated  herein  by  reference.

c)   Availability  of  Documents

The  opinion  of  Wharton  Valuation Associates, Inc. will be made available for
inspection  and  copying at the principal executive office of the Company during
its  regular  business  hours  by  any  interested equity security holder of the
Company (or such holder's representative who has been so designated in writing).
Additionally,  the  opinion  of  Wharton  Valuation  Associates,  Inc.  will  be
transmitted  by  the  Company  to  any  interested equity security holder of the
Company  (or such holder's representative who has been so designated in writing)
upon  written  request  at  the  expense  of  the  requesting  security  holder.


Item  10.   Source  and  Amounts  of  Funds  or  Other  Consideration.

Furnish  the  information  required by Item 1007 of Regulation M-A (Section
229.1007 of this  chapter).

a)   Source  of  Funds

The  total  amount of funds required by the Company to consummate the Offer (and
to  pay  related fees and expenses estimated to be approximately $128,000.00, as
described  in  the  section  of  the  Offer  to  Purchase dated January 31, 2002
entitled  "Special  Factors-Fees  and  Expenses"),  assuming that all Shares not
owned  or  controlled by Dominic Toscani and Gerard Toscani are validly tendered
and  not  withdrawn, of approximately $8,585,000 will be financed by the Company
using  available cash.   See also "THE TENDER OFFER - Financing of the Offer and
the Second Step Transaction" of the Offer to Purchase filed as exhibit (a)(1) to
Schedule  TO-I  filed  by the Company on January 31, 2002 as amended by Schedule
TO-I/A  (Amendment  No.  2)  filed  by  the  Company  on  March  5,  2002.

b)   Conditions

The  Offer  is not conditioned upon any minimum number of shares being tendered.
The  Offer  is,  however,  subject  to  certain other conditions in the Offer to
Purchase  and  related  Transmittal  Letter,  which  are  incorporated herein by
reference.  See  the section entitled "THE TENDER OFFER -- CERTAIN CONDITIONS OF
THE  OFFER,"  of  the Offer to Purchase, contained in the Schedule TO-I filed by
the  Company on January 31, 2002, which sets forth in full the conditions of the
Offer.

c)   Expenses

The  following  is  an  estimate  of  expenses  incurred  or  to  be incurred in
connection  with  the  Offer.  Also  see  the  Section  of the Offer to Purchase
entitled  "The  Tender  Offer -- Fees and Expenses" filed on Schedule TO-I dated
January  31,  2002.

Legal  Fees                 $75,000.00
Printing  and  Mailing        7,826.00
Filing  Fees.                 3,063.00
Depositary  Fees.            15,000.00
Information  Agent  Fees      5,000.00
Accountant's  Fees.          17,500.00
Miscellaneous.                5,000.00

Total                      $128,839.00


d)   Borrowed  Funds

Not  Applicable


Item  11.   Interest  in  Securities  of  the  Subject  Company.

Furnish  the  information  required by Item 1008 of Regulation M-A (Section
229.1008 of this  chapter).

a)     Securities  Ownership

                                                     AMOUNT OF
                                                     OWNERSHIP      PERCENT
            NAME                                        (1)        OF CLASS

Dominic P. Toscani(2) and  Nancy  C. Toscani         1,139,948       33.6%

The  Caritas  Foundation(3)                            383,835       11.3%
Gerard  M.  Toscani(4)                                 165,010        4.8%


(1)  Ownership  includes  both  voting  and  investment  power.

(2)  Includes  1,028,197  shares  personally  held;  47,006 shares held by Paris
Corporation Profit Sharing Plan of which Mr. Toscani is the Plan Trustee; 14,745
shares  held  by  Toscani  Investment  Company, a family partnership; and 45,000
options  exercisable  as  of  December  31,  2001.

(3)  The  Caritas  Foundation,  a  tax  exempt organization formed under Section
501(c)(3)  of  the  Internal  Revenue Code of 1954, as amended, was organized in
1984  by  Dominic P. Toscani to promote the objectives of free enterprise and to
support  individual  freedom.  At  the  present  time,  the  children of Dominic
Toscani  are  the  trustees  of  the  foundation.

(4)  Includes  58,524  shares  personally  held;  11,486  shares  held  by Paris
Corporation  Profit  Sharing Plan; and 95,000 options exercisable as of December
31,  2001.


b)     Securities  Transactions

None


Item  12.  The  Solicitation  or  Recommendation.

Furnish  the  information  required  by Item 1012(d) and (e) of Regulation M-A
(Section 229.1012  of  this  chapter).

d)  Intent  to  Tender  or  vote  in  a  going  private  transaction

Gerard  M.  Toscani,  Senior Vice President of Paris Corporation, and Dominic P.
Toscani,  President and Chief Executive Officer of Paris Corporation, who own or
control  approximately  4.8% and 44/.9%, respectively, of the outstanding Common
Stock,  have indicated that they will not tender their shares in the offer.  All
other executive officers, directors, affiliates and subsidiaries (if any) of the
filing  persons have indicated their intent to tender their shares in the offer.

If  less  than  all  of the Shares owned by the public stockholders are tendered
pursuant  to  the  Offer,  the  Company  intends  to  implement  a  Second-Step
Transaction  (as  defined  in the Offer to Purchase filed on Schedule TO-I dated
January  31,  2002),  in  which the Shares of such remaining public stockholders
would  be converted into the right to receive the Purchase Price and the Company
would  thereafter  be  dissolved.  Gerard  M. Toscani and Dominic P. Toscani who
currently  own  approximately  50%  of  the  outstanding  shares and would own a
greater  percentage  after  completion  of the Offer, intends to vote all of his
Shares  in  favor  of  the  Second-Step  Transaction  if  it  is  required.

e)  Recommendation

The Board of Directors of the Company, which consists of Dominic Toscani, Gerard
Toscani,  Frank  Mattei  (who collectively own approximately 78.3 percent of the
issued  and  outstanding  shares of the Company's common stock) and four outside
directors,  unanimously  approved  the  offer,  concluding  that  the  offer  is
advisable and that the terms of the offer are fair to, and in the best interests
of,  our  company  and  its  unaffiliated  shareholders. See "SPECIAL FACTORS --
Position  of the Company's Board; Fairness of the Offer" and "SPECIAL FACTORS --
Background  and Purpose of the Offer; Certain Effects of the Offer; Plans of the
Company  after  the  Offer" of the Schedule TO-I filed by the Company on January
31, 2002.  Gerard Toscani and Dominic Toscani, who abstained from the Board vote
because  of their potential conflict of interest, also believe the Offer is fair
to  the  other  stockholders.


Item  13.   Financial  Statements.

Furnish the information required by Item 1010(a) through (b) of Regulation M-A
(Section 229.1010  of  this  chapter)  for the issuer of the subject class
of securities.


a)    Financial  Information

The  information  set  forth  under  "The  Tender  Offer  -- Certain Information
Concerning  the  Company"  of the Offer to Purchase filed on Schedule TO-I dated
January 31, 2002, as amendment by Schedule TO/A (Amendment No. 2) dated March 5,
2002,  is  incorporated  herein by reference. In addition, the Company's audited
financial  statements  as  of  September  30,  2001  and September 30, 2000, are
included  in  the  Company's  Annual  Report  on  Form  10-K  for the year ended
September  30,  2001,  which  is  incorporated  herein  by  reference. Also, the
Company's  unaudited  financial  statements  for  the  three  month period ended
December 31, 2000 and December 31, 2001, are included in the Company's Quarterly
Report  on  Form  10-Q  for  the  period  ended  December  31,  2001,  which  is
incorporated  herein  by  reference.

b)     Pro  forma  Information

Not  Applicable


Item  14.   Persons/Assets,  Retained,  Employed,  Compensated  or  Used.

Furnish  the  information  required by Item 1009 of Regulation M-A (Section
229.1009 of this  chapter).

a)     Solicitations/Recommendations

The  Company  has retained Wharton Valuation Associates, Inc. ("Wharton") to act
as its financial advisor in connection with the Offer. The engagement letter, as
amended, between the Company and Wharton (the "Engagement Letter") provides that
the  Company is required to pay Wharton (a) a retainer fee of $7,500.00 upon the
signing  of  the Engagement Letter, plus an additional fee of $7,500.00; and (b)
an  opinion  fee  (the  "Opinion Fee") of $5,000.00. In addition, the Engagement
Letter  between the Company and Wharton provides that the Company will indemnify
Wharton  and  certain  related  persons  against  certain liabilities, including
liabilities  under  securities  laws,  arising  out  of  its  engagement.

The  Company  has  retained  MacKenzie  Partners to act as Information Agent and
Mellon  Investor Services LLC to act as Depositary in connection with the Offer.
The  Information  Agent  may  contact  holders  of  Shares  by  mail, telephone,
telegraph  and  personal  interviews  and may request brokers, dealers and other
nominee  stockholders  to  forward materials relating to the Offer to beneficial
owners.  The  Information  Agent and the Depositary will each receive reasonable
and  customary compensation for their respective services, will be reimbursed by
the  Company  for  certain  reasonable  out-of-pocket  expenses  and  will  be
indemnified  against certain liabilities in connection with the Offer, including
certain  liabilities  under  the  federal  securities  laws.

No  fees  or  commissions  will be payable by the Company to brokers, dealers or
other  persons (other than fees to the Information Agent as described above) for
soliciting  tenders of Shares pursuant to the Offer. Stockholders holding Shares
through  brokers or banks are urged to consult the brokers or banks to determine
whether  transaction  costs are applicable if stockholders tender Shares through
such  brokers or banks and not directly to the Depositary. The Company, however,
upon request, will reimburse brokers, dealers and commercial banks for customary
mailing  and  handling  expenses  incurred  by  them in forwarding the Offer and
related  materials  to the beneficial owners of Shares held by them as a nominee
or  in  a  fiduciary  capacity.

b)     Employees  and  Corporate  Assets

The  total  amount of funds required by the Company to consummate the Offer (and
to  pay  related fees and expenses estimated to be approximately $128,000.00, as
described  in  the  section  of  the  Offer  to  Purchase dated January 31, 2002
entitled  "Special  Factors-7. Fees and Expenses"), assuming that all Shares not
owned  or  controlled by Dominic Toscani and Gerard Toscani are validly tendered
and  not  withdrawn, of approximately $8,585,000 will be financed by the Company
using  available  cash.


Item  15.   Additional  Information.

Furnish the information required by Item 1011(b) of Regulation M-A (Section
229.1011 of this  chapter).

b)   Other  Material  Information

     None


Item  16.   Exhibits.

File  as  an  exhibit  to  the  Schedule all documents specified in Item 1016(a)
through  (d),  (f)  and  (g)  of  Regulation  M-A  (Section 229.1016 of
this chapter).

(a)(1)  Offer  to  Purchase*.

(a)(2)  Letter  of  Transmittal.*

(a)(3)  Notice  of  Guaranteed  Delivery.*

(a)(4)  Letter to Brokers, Dealers, Banks, Trust Companies and Other Nominees. *

(a)(5)  Letter  to  Clients  for Use by Brokers, Dealers, Banks, Trust Companies
and  Other  Nominees.*

(a)(6)  Letter  to  Shareholders  from  the  Company.*

(a)(7)  Guidelines  for  Certification  of  Taxpayer  Identification  Number  on
Substitute  Form  W-9.*

(a)(8)  Text  of  Press  Release  dated  January  10, 2002 issued by the Company
(incorporated  by  reference to the Company's Tender Offer Statement on Schedule
TO-C  filed  on  January  10,  2002).

(a)(9)  Text  of  Press  Release  dated  March  5,  2002  issued  by the Company
(incorporated  by  reference  to  Amendment  No. 1 to the Company's Tender Offer
Statement  on  Schedule  TO-I/A  filed  on  March  4,  2002).

(a)(10)  Amendment  to  Offer to Purchase (incorporated by reference to Schedule
TO-I/A  (Amendment  N0.  2)  filed  on  March  5,  2002).

(b)      None.

(c)     Opinion  of  Wharton Valuation Associates, Inc., dated November 27, 2001
(Included  as  Schedule III to the Offer to Purchase filed as exhibit (a) (1) to
Schedule  TO-I  filed  January  31,  2002).*

(d)     Employment  Agreement  dated November 8, 2001 between Dominic P. Toscani
and  Paris  Corporation.*

(f)     Section  1930  and Subchapter D of the Pennsylvania Business Corporation
Law (Included as Schedule II to the Offer to Purchase filed as exhibit (a)(1) to
Schedule  TO-I  filed  January  31,  2002).*

(g)     None.


*  Previously  filed  by  the  Company on Schedule TO-I, dated January 31, 2002.



                                   SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the
information  set  forth  in  this  statement  is  true,  complete  and  correct.


                             Dominic  P.  Toscani,  Sr.
                                 (Signature)

                       President  and  Chief  Executive  Officer
                               (Name  and  title)

                                 March  6,  2002
                                     (Date)


Instruction  to  Signature: The statement must be signed by the filing person or
that person's authorized representative. If the statement is signed on behalf of
a  person  by an authorized representative (other than an executive officer of a
corporation  or  general  partner  of  a  partnership),  evidence  of  the
representative's  authority  to  sign on behalf of the person must be filed with
the  statement.  The  name  and any title of each person who signs the statement
must  be typed or printed beneath the signature. See  240.12b-11 with respect to
signature  requirements.